287 related articles for article (PubMed ID: 34877077)
1. Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma.
Aboul-Fettouh N; Morse D; Patel J; Migden MR
Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021169S. PubMed ID: 34877077
[TBL] [Abstract][Full Text] [Related]
2. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy.
Ferini G; Palmisciano P; Forte S; Viola A; Martorana E; Parisi S; Valenti V; Fichera C; Umana GE; Pergolizzi S
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454779
[TBL] [Abstract][Full Text] [Related]
3. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
4. The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma.
Chong CY; Goh MS; Porceddu SV; Rischin D; Lim AM
Am J Clin Dermatol; 2023 Jan; 24(1):25-40. PubMed ID: 36512176
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
Fania L; Didona D; Di Pietro FR; Verkhovskaia S; Morese R; Paolino G; Donati M; Ricci F; Coco V; Ricci F; Candi E; Abeni D; Dellambra E
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33572373
[TBL] [Abstract][Full Text] [Related]
7. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
8. Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.
Argenziano G; Fargnoli MC; Fantini F; Gattoni M; Gualdi G; Pastore F; Pellacani G; Quaglino P; Queirolo P; Troiani T
Ther Adv Med Oncol; 2022; 14():17588359211066272. PubMed ID: 35035534
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma.
Boutros A; Cecchi F; Tanda ET; Croce E; Gili R; Arecco L; Spagnolo F; Queirolo P
Front Oncol; 2021; 11():733917. PubMed ID: 34513710
[TBL] [Abstract][Full Text] [Related]
10. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
11. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
Khorasanchi A; Wu R; Kendra K; Verschraegen C
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358744
[TBL] [Abstract][Full Text] [Related]
14. Patterns of major cutaneous surgeries and reconstructions in patients with cutaneous squamous cell carcinoma in the USA.
Chen CI; Jalbert JJ; Wu N; Ruiz ES
Future Oncol; 2024 Apr; 20(11):691-701. PubMed ID: 37994593
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
16. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
Ogata D; Tsuchida T
Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of advanced cutaneous squamous-cell carcinoma.
Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
[TBL] [Abstract][Full Text] [Related]
18. Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer.
Conforti C; Corneli P; Harwood C; Zalaudek I
Clin Oncol (R Coll Radiol); 2019 Nov; 31(11):759-768. PubMed ID: 31522944
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
20. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma.
Piipponen M; Riihilä P; Nissinen L; Kähäri VM
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
